Awardee OrganizationCASE WESTERN RESERVE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): Involucrin is an important precursor of the keratinocyte cornified envelope. In epidermis, expression of involucrin protein and mRNA is keratinocyte-specific and differentiation-dependent (i.e., expression is confined to the suprabasallayers). Our transgenic mouse and cell culture studies show that the human involucrin (hINV) gene upstream regulatory region is sufficient for this expression and that specific DNA elements in this region bind API, C/EBP and Spl transcription factors to drive expression. During the past funding period we identified a novel PKC, Ras, MEKK1, MEK3 and p388-ERKl/2 signaling cascade that regulates the activity and level of API, Spl and C/EBP transcription factors to increase involucrin gene expression. Although identifying this cascade represents a major step forward in our understanding of differentiation associated gene regulation, our understanding of this signal transduction cascade is far from complete. Having established the importance of this pathway, we now propose experiments designed to extend these findings. Our studies show that novel PKC isoforms, including PKC5, are the major activators of hINV gene expression in normal keratinocytes and that differentiation agents trigger tyrosine phosphorylation of PKC8 to regulate gene expression. However, the importance of PKC8 tyrosine phosphorylation in keratinocytes is complicated, controversial, and has not been thoroughly studied. Our first major goal is to identify the role of tyrosine phosphorylation of PKC8 on PKC8 activity, subcellular localization, and ability to regulate downstream signaling events. An important observation is that signal transduction in normal human keratinocytes converges at the MAPK level on p388. Our preliminary studies suggest that differential interaction of MEK3 and MEK6 with p38S may function to regulate the balance between keratinocyte differentiation and apoptosis. The second major goal of this study is to characterize the role of these kinases in regulating the balance between differentiation and apoptosis. In particular, we will focus on the role of PKC8, MEK3 and p388 in regulating keratinocyte differentiation. The overall goal of this proposal is to expand our knowledge regarding the molecular mechanisms that drive differentiation in keratinocytes. This work is particularly important, as this mitogen-activated protein kinase (MAPK) signaling cascade has been implicated in regulating keratinocyte survival, differentiation, death, and transformation. It is hoped that a better understand of this cascade willlead to new and effective therapies for epidermal disease.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
077758407
UEI
HJMKEF7EJW69
Project Start Date
01-March-2000
Project End Date
30-April-2007
Budget Start Date
01-April-2007
Budget End Date
30-April-2007
Project Funding Information for 2007
Total Funding
$38,506
Direct Costs
$24,923
Indirect Costs
$13,583
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$38,506
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AR046494-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AR046494-07
Patents
No Patents information available for 5R01AR046494-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AR046494-07
Clinical Studies
No Clinical Studies information available for 5R01AR046494-07
News and More
Related News Releases
No news release information available for 5R01AR046494-07
History
No Historical information available for 5R01AR046494-07
Similar Projects
No Similar Projects information available for 5R01AR046494-07